←Back to Expert Scholars
Translational Medicine / 转化医学Allogeneic HCT, GVHD and Immune Reconstitution
Robert Soiffer
MD
🏢Dana-Farber Cancer Institute🌐USA
Chief, Division of Hematologic Malignancies
140
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Robert Soiffer chairs hematologic malignancies at Dana-Farber and has led pivotal GVHD prevention and AML transplant trials. His research on T cell depletion, PTCy, and immune reconstitution shapes field standards. He is past president of ASTCT.
Share:
🧪Research Fields 研究领域
GVHD prevention
allogeneic HCT
immune reconstitution
AML transplant
BMT CTN
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Robert Soiffer 的研究动态
Follow Robert Soiffer's research updates
留下邮箱，当我们发布与 Robert Soiffer（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment